Neusignal Therapeutics

Developer of therapeutics for neurological disorders

placeTokyo, Tokyo, Japan calendar_todayFounded 2022 groups4 employees language neusignal-tx.com

Investor mix

9 investors on record; lead investors include Keio Innovation Initiative, Mizuho Financial Group, Mitsubishi UFJ Capital, SMBC Venture Capital.

Investor typeCountShare
Venture capital667%
Private equity111%
Bank & private debt111%
Other / undisclosed111%
Coming soon